ACXP - Acurx Pharmaceuticals files $50M mixed shelf offering
2025-07-09 17:45:34 ET
More on Acurx Pharmaceuticals
- Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript
- Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment
- Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
- Historical earnings data for Acurx Pharmaceuticals
- Financial information for Acurx Pharmaceuticals